Home About Us Our People Products Careers Global Spread Lee Principles Registration Environment Contact Us
  ACTIVE PHARMACEUTICAL INGREDIENTS FOR ADVANCED MARKETS
 
Originator
# Product Brand Company Indication DMF availability
1   Aripiprazole   Abilify   Otsuka   Antipsychotic   2nd quarter 2010
2   Clopidogrel Form I   Plavix   Sanofi   Platetelet Aggregation   Available
3   Donepezil HCl   Aricept   Eisai   Alzheimer's Dementia   1st quarter 2011
4   Duloxetine HCl   Cymbalta   Lilly   Depression   3rd quarter 2010
5   Esomeprazole Magnesium Trihydrate   Nexium   Astra Zeneca   Gastric Ulcer   2nd quarter 2010
6   Ibandronate Sodium   Boniva   Roche   Osteoporosis   2nd quarter 2010
7   Itraconazole   Sporanox   Janssen   Fungal Infections   CEP
8   Lansoprazole   Prevacid   Takeda   Gastric Ulcer   Available
9   Olanzapine Form I   Zyprexa   Lilly   Depression   Available
10   Omeprazole   Losec   Astra Zeneca   Gastric Ulcer   CEP
11   Omeprazole Magnesium   Losec   Astra Zeneca   Gastric Ulcer   1st quarter 2010
12   Omeprazole Sodium   Prilosec   Astra Zeneca   Gastric Ulcer   1st quarter 2010
13   Pantoprazole Na Sesquihydrate   Protonix   Takeda   Gastric Ulcer   4th quarter 2009
14   Pregabalin   Lyrica   Pfizer   Neuropsychiatry   3rd quarter 2010
15   Rabeprazole Na Sesquihydrate   Aciphex   Eisai   Gastric Ulcer   1st quarter 2010
16   Sertraline HCl Form II   Zoloft   Pfizer   Depression   Available
17   Venlafaxine HCl   Effexor   Wyeth   Depression   Available
18   Voriconazole   Vfend   Pfizer   Fungal Infections   Available
 
Note: APIs with non-infringing support offered wherever required
R&D Development Projects undertaken
EU CTD and US DMFs in advanced stages for generic and near expiry products
Technical Package ready for all / most of the listed products
Impurity Standards offered wherever possible
Working Standards for Actives
EU (Danish) inspected facility with complete documentation and traceability
 

©Copyright Lee Pharma Ltd. All Rights Reserved.   Powered by Camirine Tech.